Lorena Filomeno

发表

Optimizing the Choice for Adjuvant Chemotherapy in Gastric Cancer

N. Tinari, A. De Luca, S. Alberti, 2022, Cancers.

The Impact of the Hippo Pathway and Cell Metabolism on Pathological Complete Response in Locally Advanced Her2+ Breast Cancer: The TRISKELE Multicenter Prospective Study

N. Tinari, G. Ciliberto, F. Cappuzzo, 2022, Cancers.

Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA Exploration

G. Ciliberto, F. Cappuzzo, G. Sanguineti, 2022, International journal of molecular sciences.

Sexual dysfunctions in breast cancer patients: evidence in context.

G. Ciliberto, B. Chiofalo, G. Sanguineti, 2023, Sexual medicine reviews.

Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study

N. Tinari, G. Ciliberto, L. Landi, 2023, Frontiers in Oncology.

Prognostic value of gender and primary tumor location in metastatic colon cancer

N. Tinari, A. Cama, A. Grassadonia, 2023 .

DARPP-32 and t-DARPP in the development of resistance to anti-HER2 agents. Pre-clinical evidence from the STEP study

G. Ciliberto, M. Porru, G. Blandino, 2023, Neoplasia.

Breast and cervical cancer in transgender men: literature review and a case report

P. Vici, L. Pizzuti, D. Sergi, 2024, Therapeutic advances in medical oncology.

HER2 mutation as an emerging target in advanced breast cancer

L. Perracchio, P. Vici, L. Pizzuti, 2024, Cancer science.